Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Long-Term Liabilities (Tables)

v3.7.0.1
Accrued Expenses and Other Long-Term Liabilities (Tables)
3 Months Ended
Mar. 31, 2017
Components of Accrued Expenses and Other Long-Term Liabilities
 Accrued expenses and other long-term liabilities, excluding National, consisted of the following:
 
 
 
March 31,
 
December 31,
 
($ in thousands)
 
2017
 
2016
 
Accrued expenses:
 
 
 
 
 
 
 
Professional fees
 
$
1,450
 
$
1,253
 
Salaries, bonuses and related benefits
 
 
3,532
 
 
2,846
 
Accrued Severance
 
 
-
 
 
53
 
Ovamed manufacturing rights – short term component
 
 
900
 
 
900
 
Research and development
 
 
680
 
 
394
 
Dr. Falk Pharma milestone
 
 
2,684
 
 
2,634
 
Other
 
 
1,874
 
 
2,002
 
Total accrued expenses
 
$
11,120
 
$
10,082
 
 
 
 
 
 
 
 
 
Other long-term liabilities:
 
 
 
 
 
 
 
Deferred rent and long-term lease abandonment charge
 
 
5,020
 
 
5,014
 
Total other long-term liabilities
 
$
5,020
 
$
5,014
 
National Holdings Corporation [Member]  
Components of Accrued Expenses and Other Long-Term Liabilities
National’s accounts payable and other accrued expenses as of December 31, 2016, consisted of the following:
 
 
 
December 31,
 
 
 
2016
 
Legal
 
$
752
 
Audit
 
 
263
 
Telecommunications
 
 
178
 
Data Services
 
 
235
 
Regulatory
 
 
623
 
Settlements
 
 
421
 
Deferred rent
 
 
123
 
Contingent consideration payable
 
 
623
 
Other
 
 
1,995
 
Total
 
$
5,213